CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Clinical trial NCT02937558 · COMPLETED
Trial details
- NCT number
- NCT02937558
- Sponsor
- Xeris Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.